Journey Medical Corp (DERM) — Cash Flow Reinvestment Rate
Journey Medical Corp (DERM) has a Cash Flow Reinvestment Rate of 6.74x as of December 2024, reinvesting $15.00 Million (capex $0.00 plus investments $-15.00 Million) from operating cash flow of $2.23 Million. See DERM free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Journey Medical Corp Cash Flow Reinvestment Rate (2019–2023)
Historical reinvestment intensity for Journey Medical Corp across 3 annual periods. For the full cash flow conversion analysis, see Journey Medical Corp (DERM) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Journey Medical Corp (2019–2023)
Year-by-year capital reinvestment analysis for Journey Medical Corp. See financial flexibility index of Journey Medical Corp to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.91x | $10.00 Million | $5.24 Million | $5.00 Million | ▲ +308.1% |
| 2020 | 0.47x | $2.40 Million | $5.13 Million | $1.20 Million | ▼ -12.1% |
| 2019 | 0.53x | $4.80 Million | $9.02 Million | $2.40 Million | — |